Scroll to Top

USA Stock Report

Real Time Stocks News

Boston, MA, 04/10/2014  (usastockreport) – A corporation specialized in biopharmaceutical R&D and oncology; CytRx Corporation (NASDAQ:CYTR) is investing hugely in recent findings to improve the phase of medical procedures. However, while it is slowly moving towards making new investments and carving out new niches, there are some hiccups in the form of litigation...